Gossamer Bio, Inc.
February 20, 2024 - by Joey Ramson
$GOSS, a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension, is the leader of the Prism MarketView Public Health index so far today.
